ArticleBMJ global health2026
A systems approach to understanding mechanisms underlying immunisation barriers: a participatory design study in Tanzania.
Article in BMJ global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe underlying causes of supply-side and demand-side challenges in immunisation are poorly understood, leading to symptomatic solutions. This study engaged stakeholders to develop model-based tools for understanding underlying mechanisms, addressing barriers and supporting the design of interventions and policies for immunisation services in Tanzania.
methodsBetween March 2023 and April 2024, we conducted a qualitative study involving eight in-depth interviews, 12 focus group discussions with 75 participants, and two participatory group model building workshops with 14-16 participants each. Immunisation stakeholders including vaccinators, vaccine coordinators, programme managers, community members and non-governmental organisations provided insights on barriers and facilitators to immunisation access, supply and demand. Their perspectives, combined with evidence from scientific and grey literature, informed the development of a causal loop diagram of immunisation in Tanzania, exploring potential leverage points for improvement.
resultsSeveral feedback mechanisms influencing vaccine uptake were identified, including vaccine confidence, risk-benefit perception, vaccine operations (planning, distribution and administration), health workforce, awareness campaigns, safety communication, service accessibility and service quality. Concerns about vaccine safety reduce willingness to vaccinate while limited accessibility and poor service quality diminish motivation to attend sessions. Despite early recovery efforts, the COVID-19 pandemic impacted these mechanisms, exacerbating misinformation, workforce and financial shortages, decreasing vaccine uptake and exposing weak system resilience. Barriers related to infrastructure, accessibility, workforce and service quality varied by region, with rural areas facing greater obstacles. Overall, immunisation resilience and sustainability remain vulnerable due to insufficient investment.
conclusionLinking demand and supply dynamics highlights potential leverage points for sustainable and resilient immunisation services, including vaccine acceptability and operational challenges. Addressing these requires adequate investments and accountability in vaccine safety surveillance and communication, awareness campaigns, vaccination sites, workforce capacity and effective vaccine operations. Quantitative modelling and scenario analysis are needed to confirm leverage points and design effective interventions and policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.